# Re-Gen Active Lab Inc – FDA Inspection, Sep 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/re-gen-active-lab-inc/8f9f7775-7ffe-42d0-b561-2c784b4c2ada
Source feed: FDA_Inspections

> FDA inspection 1218428 of Re-Gen Active Lab Inc, September 21, 2023. 13 citations under 21 CFR parts 211 and 610. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1218428
- Company Name: Re-Gen Active Lab Inc
- Inspection Date: 2023-09-21
- Center: Biologics
- Office Name: Dallas District Office
- Citation Count: 13

## Related Documents

- [FDA Inspection 1147426 - 2021-07-28](https://www.keypedia.com/records/fda_inspections/re-gen-active-lab-inc/5e515cb4-157c-4cc1-aaf4-9321aa83eb58)

## Related Officers

- [Emily S. McGann](https://www.keypedia.com/people/emily-s-mcgann/43891ff3-bd70-4337-b61c-e16cc7ad0468)
- [Issuing Officer](https://www.keypedia.com/people/william-f-lagud/c90c4bd6-bb56-4a60-a5f8-cbc648bb8dbe)

Company: https://www.keypedia.com/companies/re-gen-active-lab-inc/348e9f01-5a00-415d-9322-83f379a0e943

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9
